Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market - GBI Research Reports

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market - GBI Research Reports
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
Published Jul 01, 2011
103 pages — Published Jul 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest report, Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market which provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Brazil. The report provides a comprehensive insight of the reasons for outsourcing clinical trials to Brazil and the key services provided by the Clinical Research Organizations (CROs) of Brazil. The report provides a detailed analysis of the Brazilian market in terms of its size, and major service offerings of the CROs in Brazil. The report also discusses the factors that are driving the clinical trial market in Brazil. The report delves into the key documents required by the investigator and the sponsor before, during and after the conduct of clinical trials. The report also provides key alliances between the CROs of other countries and the local CROs of Brazil. Furthermore, the report looks into the major challenges that can restrict the growth of the clinical trials market in Brazil.

Scope

The report analyses the clinical trial market in Brazil, along with the major forces driving the current market and the potential challenges that could restrain the growth. The scope of the report includes -
- The need for outsourcing clinical trials to Brazil.
- Trends in clinical trial registration in Brazil and a comparative analysis of clinical trial registration in Brazil, Russia, India and China (BRIC) and six major Latin American countries.
- Analysis of the key drivers that are fueling the growth of the clinical trial market in Brazil.
- Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Brazil.
- Analysis of key government regulations in Brazil affecting the clinical trial market.
- Study of 13 major CROs operating in Brazil with SWOT analysis of large multinational CROs.

Reasons to buy

The report will enhance your decision making capability in a rapid and time-sensitive manner. It will allow you to -
- Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs.
- Develop market entry and market expansion strategies by identifying the key drivers and challenges in the Brazilian clinical trials market.
- Develop effective strategies to maximize the advantages in Brazil through understanding of the regulatory environment.
- Understand the regulatory structure in Brazil and key documents required to register clinical trials in Brazil.

  
Source:
Document ID
GBIHC109MR
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market" Jul 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Market-for-Clinical-Trials-in-Brazil-Improved-Guidelines-from-ANVISA-and-CONEP-are-Shortening-the-Regulatory-Approval-Process-and-Advancing-the-Market-2115-233>
  
APA:
GBI Research Reports. (2011). Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market Jul 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Market-for-Clinical-Trials-in-Brazil-Improved-Guidelines-from-ANVISA-and-CONEP-are-Shortening-the-Regulatory-Approval-Process-and-Advancing-the-Market-2115-233>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.